The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial.
- Resource Type
- Article
- Source
- Journal of Urology; Jul2017, Vol. 198 Issue 1, p167-175, 9p
- Subject
- Language
- ISSN
- 00225347